Results 71 to 80 of about 3,591 (202)

Distributionally Robust Expansion Planning Considering Flexibility for Distribution Network With Soft Open Points

IET Energy Systems Integration, Volume 8, Issue 1, January/December 2026.
ABSTRACT The rapid integration of renewable energy generators (REGs) alongside flexibility resources into the grid introduces significant data complexities, alongside increased unpredictability and variability within the distribution network. Reasonable allocation of flexibility resources can improve the utilisation of REGs and the flexibility of the ...
Qianyu Zhao, Luyang Wang, Xiang Li, Shouxiang Wang, Lanqian Yang, Yanming Tian   +5 more
wiley   +1 more source

Subsecretaria de Ciencias Carolina Torrealba y su par de Economía Ignacio Toro Guerrero, visitan el CINV

, 2019
El CINV, contó con la visita de diversas autoridades entre las que destacamos a Carolina Torrealba, Subsecretaria de Ciencia, Ignacio Toro Guerrero, Subsecretario de Economía.
Salazar, Matias
core   +1 more source

Evolution Framework for Power Generation Mix Planning From Perspective of Economic Growth

IET Generation, Transmission &Distribution, Volume 20, Issue 1, January/December 2026.
This study develops a decomposition‐based intertemporal dynamic soft‐linking framework that couples a forward‐looking economic growth model with a technically detailed power generation expansion planning model. Using environmental expenditure and electricity environmental efficiency as coupling variables, the framework evaluates long‐term trade‐offs ...
Gang Lu, Bo Yuan, Lei Tang, Xue Xu, Shijun Tian, ZhiCheng Wang   +5 more
wiley   +1 more source

Assessment of various risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting amongst patients receiving concurrent chemoradiotherapy: A prospective study

Journal of Clinical and Scientific Research
Background: Chemotherapy-induced nausea and vomiting (CINV) is the most common side effects in the treatment of solid tumours. Sparse data are available regarding risk factors for CINV from India.
S. Navaneetha Krishnan, Pranabandhu Das, Divya Bharathi Manikonda, Dharmika Naramsetti, Jayasree Puthalapattu, Jeswitha Velagambatti, B. V. Subramanian, Battula Pradeep   +7 more
doaj   +1 more source

Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial

International Journal of Women's Health, 2023
Apichaya Sukpiriyagul,1 Ratiporn Chartchaiyarerk,1 Paluekpon Tabtipwon,1 Buppa Smanchat,1 Sinart Prommas,1 Kornkarn Bhamarapravatana,2 Komsun Suwannarurk3 1Department of Obstetrics and Gynecology, Bhumibol Adulyadej Hospital, Royal Thai Air Force Bangkok
Sukpiriyagul A, Chartchaiyarerk R, Tabtipwon P, Smanchat B, Prommas S, Bhamarapravatana K, Suwannarurk K   +6 more
doaj  

Knowledge, Attitudes, and Practices: Preventing Delayed CINV with Antiemetics

Introduction: Chemotherapy-induced nausea and vomiting (CINV) is the most feared side effect by cancer patients. To prevent and minimize the occurrence of delayed CINV, patients are given post-chemotherapy antiemetics.
Suharjono Suharjono, Muhammad Darwin Prenggono, Aditya Maulana Perdana Putra, Ratih Pratiwi Sari, Mahardian Rahmadi   +4 more
core   +1 more source

Evaluation of a neurokinin-1 antagonist in preventing multiple-day cisplatin-induced nausea and vomiting

Open Medicine, 2018
To perform a prospective non-randomized comparison of the effectiveness and safety of combined neurokinin-1 antagonist aprepitant treatment with the standard multiple-day cisplatin regimen for the prevention of cisplatin-induced nausea and vomiting (CINV)
Li Quanfu, Wang Wenjuan, Chen Gang, Deng Shuqin, Jiang Caihong, Chen Feng, Zhao Jun, Li Hui, Bai Xiaojun, Hu Yuliang, Da Lenggaowa, Wu Yungaowa, Jin Gaowa   +12 more
doaj   +1 more source

CINV Survey

, 2016
Introduction: Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of chemotherapeutic treatment experienced by dogs that can lower quality of life and functionality.
Hackbarth, Lauren
core  

Association of chemotherapy-induced nausea and vomiting or anorexia with plasma levels of five gastrointestinal peptides in patients receiving chemotherapy

Journal of Pharmaceutical Health Care and Sciences
Background Imbalance between gastrointestinal peptides has been implicated as a cause of chemotherapy-induced nausea and vomiting (CINV) and anorexia in cancer patients.
Ryosuke Tatsuta, Ryota Tanaka, Asami Tashibu, Yosuke Suzuki, Kosuke Suzuki, Tomotaka Shibata, Tadasuke Ando, Toshitaka Shin, Yuhki Sato, Hiroki Itoh   +9 more
doaj   +1 more source

The emerging role of olanzapine in paediatric CINV control: A review

Medicine, 2022
Chemotherapy-induced nausea and vomiting (CINV) is a serious side effect of chemotherapy that negatively impacts the quality of life of oncological patients and is associated with the emetogenic risk specific to administered chemotherapy. Current practice guidelines on the use of antiemetics in CINV include the option of adding olanzapine to antiemetic
openaire   +2 more sources